2026 Q3 Portfolio Activity
In 2026 Q3, Redmile Group, LLC maintained a portfolio of 45 distinct positions. The most significant new addition was ELECTRA THERAPEUTICS INC, now representing 4.47% of the total fund value. They heavily accumulated shares in NURIX THERAPEUTICS INC, increasing the position by 93.9%. The fund also reduced its exposure to SCHOLAR ROCK HLDG CORP by 29.6%.
Position History
hover any row below to update
Loading…
Total Positions
45
Quarter
2026 Q3
Top Holding
NRIX (13.7%)
Top 10 Concentration
71.6%
Turnover Rate
23.4%
Sector HHI
0.18
Items per page:
Showing 1-45 of 45
Redmile Group, LLC Full Holdings List — 2026 Q3
| Stock | History | Sector / Type | Port % | Prev % | Rank / Prev | Conviction | Change | % Change | Influence | Shares | Mkt Value | Avg Cost | Price Held | 1st Owned | Source | Source Date | Date Reported | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
NRIX
NURIX THERAPEUT...
|
Healthcare | 13.71% | 6.64% |
#1
4
Prev: #5
|
9.0 |
—
|
3,827,298 | 93.9% |
P
S
|
7,901,085 | $187,334,725 | 2020 Q3 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
KRYS
KRYSTAL BIOTECH...
|
Healthcare | 12.84% | 15.77% |
#2
Prev: #2
|
6.0 |
—
|
-104,321 | -16.5% |
P
S
|
527,684 | $175,486,591 | 2018 Q4 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
SRRK
SCHOLAR ROCK HL...
|
Healthcare | 10.73% | 15.92% |
#3
2
Prev: #1
|
5.0 |
—
|
-1,277,130 | -29.6% |
P
S
|
3,033,962 | $146,601,044 | 2018 Q2 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
STOK
STOKE THERAPEUT...
|
Healthcare | 7.36% | 8.67% |
#4
1
Prev: #3
|
3.9 |
—
|
-76,892 | -1.9% |
P
S
|
3,869,028 | $100,594,728 | 2019 Q2 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
IMNM
IMMUNOME INC
|
Healthcare | 6.87% | 6.99% |
#5
1
Prev: #4
|
3.7 |
—
|
-548,526 | -11.2% |
P
S
|
4,363,064 | $93,849,507 | 2023 Q4 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
ABSI
ABSCI CORPORATI...
|
Healthcare | 5.26% | 5.24% |
#6
Prev: #6
|
2.6 |
—
|
-68,298 | -1.0% |
P
S
|
6,671,377 | $71,850,730 | 2021 Q3 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
ETRA
ELECTRA THERAPE...
|
Healthcare | 4.47% | — |
#7
Prev: #—
|
5.3 |
—
|
5,430,918 | — |
NEW
|
5,430,918 | $61,097,828 | 2026 Q3 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
ANNX
ANNEXON INC
|
Healthcare | 4.42% | 4.55% |
#8
1
Prev: #7
|
4.3 |
—
|
2,408,198 | 20.3% |
P
S
|
14,278,075 | $60,396,257 | 2020 Q3 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
NGNE
NEUROGENE INC
|
Healthcare | 3.18% | 2.98% |
#9
1
Prev: #10
|
3.3 |
—
|
150,000 | 10.6% |
P
S
|
1,562,199 | $43,460,376 | 2023 Q4 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
RGNX
REGENXBIO INC
|
Healthcare | 2.78% | 3.51% |
#10
2
Prev: #8
|
3.1 |
—
|
679,698 | 15.6% |
P
S
|
5,048,502 | $38,015,220 | 2015 Q3 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
STTK
SHATTUCK LABS I...
|
Healthcare | 2.54% | 3.21% |
#11
2
Prev: #9
|
1.0 |
—
|
-1,805,043 | -26.2% |
P
S
|
5,086,990 | $34,693,272 | 2020 Q4 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
FATE
FATE THERAPEUTI...
|
Healthcare | 2.23% | 2.33% |
#12
1
Prev: #13
|
1.9 |
—
|
no change | no change |
P
S
|
12,872,946 | $30,508,882 | 2015 Q2 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
SLN
SILENCE THERAPE...
|
Healthcare | 1.97% | 1.60% |
#13
2
Prev: #15
|
2.8 |
—
|
296,117 | 13.7% |
P
S
|
2,460,894 | $26,897,571 | 2024 Q1 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
BEAM
BEAM THERAPEUTI...
|
Healthcare | 1.90% | 2.68% |
#14
3
Prev: #11
|
1.3 |
—
|
-102,477 | -8.8% |
P
S
|
1,061,782 | $25,960,570 | 2020 Q1 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
N/A
ATTOVIA THERAPE...
|
|
Unknown | 1.46% | — |
#15
Prev: #—
|
4.1 |
—
|
1,163,587 | — |
NEW
|
1,163,587 | $19,943,881 | — | 13F Filing | 2026-09-30 | 2026-11-16 | ||
|
AGMB
AGOMAB THERAPEU...
|
Healthcare | 1.41% | 2.38% |
#16
4
Prev: #12
|
0.6 |
—
|
-993,696 | -36.3% |
P
S
|
1,740,230 | $19,316,553 | 2026 Q1 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
NUVB
NUVATION BIO IN...
|
Healthcare | 1.24% | 1.16% |
#17
1
Prev: #18
|
1.5 |
—
|
no change | no change |
P
S
|
3,031,009 | $16,973,650 | 2021 Q1 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
ADRX
ADARX PHARMACEU...
|
Healthcare | 1.12% | — |
#18
Prev: #—
|
3.9 |
—
|
769,345 | — |
NEW
|
769,345 | $15,340,739 | 2026 Q3 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
IDYA
IDEAYA BIOSCIEN...
|
Healthcare | 1.07% | 1.60% |
#19
5
Prev: #14
|
0.4 |
—
|
-258,883 | -40.4% |
P
S
|
381,319 | $14,650,276 | 2023 Q4 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
ADCT
ADC THERAPEUTIC...
|
Healthcare | 1.03% | 0.83% |
#20
5
Prev: #25
|
0.9 |
—
|
57,842 | 0.5% |
P
S
|
11,584,552 | $14,133,153 | 2020 Q2 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
SLDB
SOLID BIOSCIENC...
|
Healthcare | 1.03% | 1.31% |
#21
4
Prev: #17
|
0.9 |
—
|
-4,353 | -0.2% |
P
S
|
1,944,342 | $14,057,593 | 2024 Q4 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
ZYME
ZYMEWORKS INC
|
Healthcare | 0.95% | 0.86% |
#22
2
Prev: #24
|
1.4 |
—
|
no change | no change |
P
S
|
491,654 | $13,023,914 | 2022 Q4 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
OBX
OBSIDIAN THERAP...
|
Healthcare | 0.84% | — |
#23
Prev: #—
|
3.8 |
—
|
833,157 | — |
NEW
|
833,157 | $11,439,246 | 2026 Q3 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
BMRN
BIOMARIN PHARMA...
|
Healthcare | 0.83% | 1.02% |
#24
2
Prev: #22
|
0.3 |
—
|
-75,631 | -28.5% |
P
S
|
189,538 | $11,372,280 | 2007 Q4 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
CLYM
CLIMB BIO INC
|
Healthcare | 0.82% | 1.07% |
#25
5
Prev: #20
|
0.3 |
—
|
-251,841 | -20.5% |
P
S
|
974,489 | $11,177,389 | 2026 Q2 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
CLDX
CELLDEX THERAPE...
|
Healthcare | 0.76% | 1.08% |
#26
7
Prev: #19
|
0.3 |
—
|
-112,151 | -25.8% |
P
S
|
321,770 | $10,428,566 | 2020 Q2 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
ALXO
ALX ONCOLOGY HL...
|
Healthcare | 0.73% | 1.03% |
#27
6
Prev: #21
|
0.8 |
—
|
-207,241 | -2.8% |
P
S
|
7,185,263 | $9,987,516 | 2020 Q3 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
AURA
AURA BIOSCIENCE...
|
Healthcare | 0.71% | 0.79% |
#28
2
Prev: #26
|
0.8 |
—
|
-114,188 | -6.9% |
P
S
|
1,552,479 | $9,749,568 | 2026 Q2 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
COGT
COGENT BIOSCIEN...
|
Healthcare | 0.70% | 1.31% |
#29
13
Prev: #16
|
0.3 |
—
|
-206,715 | -41.1% |
P
S
|
296,606 | $9,497,324 | 2023 Q2 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
CBLL
CERIBELL INC
|
Healthcare | 0.69% | 0.51% |
#30
Prev: #30
|
1.3 |
—
|
no change | no change |
P
S
|
386,786 | $9,433,711 | 2024 Q4 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
ODTX
ODYSSEY THERAPE...
|
Healthcare | 0.61% | 0.53% |
#31
4
Prev: #27
|
0.7 |
—
|
-50,490 | -11.9% |
P
S
|
374,510 | $8,321,612 | 2026 Q2 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
XENE
XENON PHARMACEU...
|
Healthcare | 0.52% | 0.93% |
#32
9
Prev: #23
|
0.7 |
—
|
-38,338 | -16.7% |
P
S
|
191,036 | $7,104,629 | 2022 Q2 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
LIVN
LIVANOVA PLC
|
Healthcare | 0.47% | 0.51% |
#33
5
Prev: #28
|
0.7 |
—
|
-9,022 | -9.7% |
P
S
|
84,132 | $6,436,098 | 2017 Q2 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
ATRA
ATARA BIOTHERAP...
|
Healthcare | 0.40% | 0.34% |
#34
Prev: #34
|
2.7 |
—
|
195,151 | 44.2% |
P
S
|
636,852 | $5,413,242 | 2024 Q2 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
INSM
INSMED INC
|
Healthcare | 0.36% | 0.37% |
#35
3
Prev: #32
|
0.6 |
—
|
-8,332 | -16.3% |
P
S
|
42,902 | $4,896,834 | 2014 Q3 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
EPRX
EUPRAXIA PHARMA...
|
Healthcare | 0.35% | 0.27% |
#36
1
Prev: #35
|
0.6 |
—
|
-91,519 | -15.0% |
P
S
|
519,881 | $4,730,917 | 2026 Q1 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
DBVT
DBV TECHNOLOGIE...
|
Healthcare | 0.32% | 0.45% |
#37
6
Prev: #31
|
0.6 |
—
|
-37,023 | -9.0% |
P
S
|
373,417 | $4,391,384 | 2025 Q4 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
ORIC
ORIC PHARMACEUT...
|
Healthcare | 0.29% | 0.26% |
#38
2
Prev: #36
|
0.6 |
—
|
-69,193 | -19.1% |
P
S
|
292,817 | $3,944,245 | 2025 Q4 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
N/A
TCGX ACQUISITIO...
|
|
Unknown | 0.27% | — |
#39
Prev: #—
|
3.6 |
—
|
299,860 | — |
NEW
|
299,860 | $3,751,249 | — | 13F Filing | 2026-09-30 | 2026-11-16 | ||
|
PRME
PRIME MEDICINE ...
|
Healthcare | 0.26% | 0.34% |
#40
7
Prev: #33
|
0.6 |
—
|
-242,772 | -17.5% |
P
S
|
1,146,860 | $3,503,657 | 2022 Q4 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
IVVD
INVIVYD INC
|
Healthcare | 0.15% | 0.15% |
#41
3
Prev: #38
|
0.6 |
—
|
-312,439 | -12.0% |
P
S
|
2,285,320 | $1,988,457 | 2021 Q3 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
OCUL
OCULAR THERAPEU...
|
Healthcare | 0.14% | — |
#42
Prev: #—
|
3.6 |
—
|
243,954 | — |
NEW
|
243,954 | $1,871,127 | 2026 Q3 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
ARDX
ARDELYX INC
|
Healthcare | 0.13% | 0.22% |
#43
6
Prev: #37
|
0.6 |
—
|
-117,880 | -18.4% |
P
S
|
523,870 | $1,791,635 | 2019 Q4 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
PLRX
PLIANT THERAPEU...
|
Healthcare | 0.06% | 0.06% |
#44
5
Prev: #39
|
1.0 |
—
|
no change | no change |
P
S
|
772,126 | $833,896 | 2020 Q2 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
ESTA
ESTABLISHMENT L...
|
Healthcare | 0.00% | 0.51% |
Sold All 😨
(Was: #29) |
0.0 |
—
|
-88,964 | -100.0% |
CLOSED
|
— | $— | 2018 Q3 | 13F Filing | 2026-09-30 | 2026-11-16 |
Showing 1-45 of 45 holdings